1-5 of 5
Authors: Jose A Carrillo
Journal Article
A phase I dose-escalation study of pulsatile afatinib in patients with recurrent or progressive brain cancer Open Access
Neuro-Oncology Advances, Volume 6, Issue 1, January-December 2024, vdae049, https://doi.org/10.1093/noajnl/vdae049
Published: 30 March 2024
Journal Article
CTIM-33. PHASE II TRIAL OF VACCINE IMMUNOTHERAPY IN PRIMARY GLIOBLASTOMA: ADJUNCTIVE AUTOLOGOUS DENDRITIC CELLS PULSED WITH LYSATE FROM IRRADIATED SELF-RENEWING AUTOLOGOUS TUMOR CELLS (AV-GBM-1) Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi58, https://doi.org/10.1093/neuonc/noab196.225
Published: 12 November 2021
Journal Article
ACTR-10. A RANDOMIZED, PHASE I/II TRIAL OF IXAZOMIB IN COMBINATION WITH STANDARD THERAPY FOR UPFRONT TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED MGMT METHYLATED GLIOBLASTOMA (GBM) STUDY DESIGN Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi13, https://doi.org/10.1093/neuonc/noy148.045
Published: 05 November 2018
Journal Article
ATIM-28. PHASE 2 STUDY OF ERC1671 PLUS BEVACIZUMAB VS BEVACIZUMAB PLUS PLACEBO IN RECURRENT GBM INTERIM RESULTS AND CORRELATIONS WITH CD4+ T LYMPHOCYTE COUNTS Free
Neuro-Oncology, Volume 20, Issue suppl_6, November 2018, Page vi7, https://doi.org/10.1093/neuonc/noy148.023
Published: 05 November 2018
Journal Article
Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome Get access
Neuro-Oncology, Volume 15, Issue 3, March 2013, Pages 370–381, https://doi.org/10.1093/neuonc/nos308
Published: 17 January 2013
